Cargando…

Dissecting the immune cell landscape in hepatocellular carcinoma—are we understanding complexity?

Detalles Bibliográficos
Autor principal:	Ocker, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327369/ https://www.ncbi.nlm.nih.gov/pubmed/32617286 http://dx.doi.org/10.21037/atm.2020.03.170

Ejemplares similares

Biomarkers for hepatocellular carcinoma: What’s new on the horizon?
por: Ocker, Matthias
Publicado: (2018)

The immune landscape of hepatocellular carcinoma-where we are?
por: Gryziak, Maciej, et al.
Publicado: (2022)

Immune Cytolytic Activity for Comprehensive Understanding of Immune Landscape in Hepatocellular Carcinoma
por: Takahashi, Hideo, et al.
Publicado: (2020)

Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
por: Neureiter, Daniel, et al.
Publicado: (2019)

Toward a Better Understanding of Hepatocellular Carcinoma Immune Infiltrates
por: Buettner, Nico, et al.
Publicado: (2019)

The complexity of immune cell landscape in hepatocellular carcinomas with different risks—reply letter
por: Tang, Xiaofeng, et al.
Publicado: (2020)

The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We?
por: Hu, Xin, et al.
Publicado: (2022)

Estrogen, estrogen receptors, and hepatocellular carcinoma: Are we there yet?
por: Sukocheva, Olga A
Publicado: (2018)

Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma
por: Ocker, Matthias
Publicado: (2020)

Hepatocellular carcinoma mutation landscape and its differences between Asians and Whites
por: Chen, Xingte, et al.
Publicado: (2022)

Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma
por: Rohr-Udilova, Nataliya, et al.
Publicado: (2018)

Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies
por: Giraud, Julie, et al.
Publicado: (2021)

Which treatment modality should we choose for advanced hepatocellular carcinoma?
por: Kim, Do Young
Publicado: (2010)

Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we
por: Tsoulfas, Georgios
Publicado: (2019)

Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2023)

Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells
por: Gao, Xiaoqiang, et al.
Publicado: (2023)

Understanding hybrid endoscopic submucosal dissection subtleties
por: Pontual, João Paulo de Souza, et al.
Publicado: (2023)

Are We There Yet? Emerging Milestones in Aortic Dissection Care
por: Svensson, Lars G.
Publicado: (2019)

Interplay of Cardiac and Cognitive Function: How Much Do We Really Understand?
por: Friedrich, Matthias G.
Publicado: (2015)

You BETer be aware – learnings from a negative Phase 1 study
por: Postel-Vinay, Sophie, et al.
Publicado: (2019)

Hepatocellular adenoma: Where are we now?
por: Wang, Xi, et al.
Publicado: (2022)

Dissecting the expression landscape of cytochromes P450 in hepatocellular carcinoma: towards novel molecular biomarkers
por: Brodeur, Camille Martenon, et al.
Publicado: (2019)

Understanding the Natural History of Bicuspid Aortic Valve: Are We Close to Understanding It?
por: Lee, Seung-Pyo
Publicado: (2019)

Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
por: Machairas, Nikolaos, et al.
Publicado: (2022)

Current Landscape of Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
por: Ruff, Samantha M., et al.
Publicado: (2023)

The Landscape of Immune Cells Indicates Prognosis and Applicability of Checkpoint Therapy in Hepatocellular Carcinoma
por: Huang, Jiacheng, et al.
Publicado: (2021)

The Heterogeneity of Immune Cell Infiltration Landscape and Its Immunotherapeutic Implications in Hepatocellular Carcinoma
por: Guo, Yuanyuan, et al.
Publicado: (2022)

Microwave thermosphere versus radiofrequency ablation for hepatocellular carcinoma: Are we approaching the time to end the debate?
por: Kim, Man-Deuk
Publicado: (2021)

Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future
por: Ocker, Matthias, et al.
Publicado: (2021)

Editorial: Novel therapeutic approaches for biliary tract cancer and hepatocellular carcinoma
por: Bekric, Dino, et al.
Publicado: (2023)

Dissecting the Immune Landscape of Acute Myeloid Leukemia
por: Davidson-Moncada, Jan, et al.
Publicado: (2018)

Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation
por: Bekric, Dino, et al.
Publicado: (2022)

The mutational landscape of hepatocellular carcinoma
por: Lee, Ju-Seog
Publicado: (2015)

The fusion landscape of hepatocellular carcinoma
por: Zhu, Chengpei, et al.
Publicado: (2019)

Brazilian Landscape of Hepatocellular Carcinoma
por: Fonseca, Leonardo G., et al.
Publicado: (2023)

Very-early-stage Hepatocellular Carcinoma, Are We at Long Last on Route for Achieving Better Patient Outcomes?
por: Vidal-Cevallos, Paulina, et al.
Publicado: (2021)

Therapeutic Landscapes in Colorectal Carcinoma
por: Scanu, Antonio Mario, et al.
Publicado: (2023)

Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma
por: Qin, Peng, et al.
Publicado: (2021)

Comprehensive Analyses of the Infiltrating Immune Cell Landscape and Its Clinical Significance in Hepatocellular Carcinoma
por: Zhang, Zeyu, et al.
Publicado: (2021)

Identification of the Immune Cell Infiltration Landscape in Hepatocellular Carcinoma to Predict Prognosis and Guide Immunotherapy
por: Yang, Shiyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_khb9ebk3tb0t7tadiutb14acdk